Research across Heart Failure
Related studies from across the Heart Failure family.
Heart transplantation provides feasible treatment with favorable long-term survival for end-stage Chagas heart disease
Heart transplant offers long term survival for Chagas heart disease
This meta-analysis of 305 patients evaluates outcomes in Chagas heart disease transplant recipients. The analysis indicates that heart trans…
Heart transplants provide a viable path to long term survival for patients with advanced Chagas heart disease.
Nursing-led strategies address patient, systemic, and socio-cultural barriers to cardiac rehabilitation participation
Nurses help heart failure patients overcome barriers to cardiac rehab
This systematic review of 17 studies identifies nursing-led interventions as key facilitators for overcoming barriers to cardiac rehabilitat…
Many heart failure patients struggle to join rehab due to fear or travel issues, but nurse-led support can help them stay on track.
Dapagliflozin associated with lower risk of heart failure in frail patients with aortic stenosis
Trial shows dapagliflozin may help frail patients with aortic stenosis
This post hoc analysis examined the impact of dapagliflozin on patients with severe aortic stenosis undergoing transcatheter aortic valve im…
A new analysis suggests the medication dapagliflozin may offer specific benefits for patients with aortic stenosis who are also experiencing…
Cardiac resynchronization therapy increases left ventricular ejection fraction by 9.95% in cancer-related heart failure
Heart therapy shows promise for cancer patients with heart damage
This meta-analysis of 110 patients with cancer therapy-related cardiac dysfunction found that cardiac resynchronization therapy (CRT) increa…
A new look at heart treatments shows that a specific device can improve heart function for cancer survivors with heart damage.
Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival
Mechanical Support for Cardiogenic Shock Does Not Uniformly Improve Survival
This mini review examines the role of short-term mechanical circulatory support (MCS) in patients with cardiogenic shock, including those wi…
Newer reviews suggest that while mechanical support helps heart function, it does not always lead to better survival rates for patients in c…
Qili Qiangxin plus conventional medicine improves surrogate markers in heart failure after myocardial infarction
Qili Qiangxin May Improve Heart Function After Heart Attack
This meta-analysis of 1391 patients found that Qili Qiangxin combined with conventional Western medicine led to greater reductions in NT-pro…
Adding Qili Qiangxin to standard medicine may improve heart function and quality of life for patients following a heart attack.
RAAS inhibitors modulate inflammatory responses and oxidative stress across multiple chronic conditions
RAAS Inhibitors May Protect Organs Beyond Lowering Blood Pressure
This systematic review synthesizes the roles of ACEI, ARB, DRI, ARNI, and MRA in modulating inflammatory responses and oxidative stress. The…
New research suggests certain blood pressure medications may protect the heart, kidneys, and lungs by reducing inflammation and oxidative st…
An RV-first framework addresses controversies in tricuspid intervention and right ventricular support for cardiogenic shock
New framework aims to improve care for heart failure patients
This narrative review explores the role of transcatheter tricuspid interventions and mechanical circulatory support for patients with advanc…
Doctors are looking for better ways to treat heart failure and cardiogenic shock using a new approach to manage the right side of the heart.
SGLT-2is and GLP-1RAs significantly reduce heart failure related composite endpoints in type 2 diabetes
SGLT2 inhibitors and GLP-1RAs both improve heart failure outcomes
This network meta-analysis of 13,886 patients with type 2 diabetes and heart failure found that both SGLT-2is and GLP-1RAs significantly red…
New data shows both SGLT2 inhibitors and GLP-1RAs effectively reduce heart failure risks for people with type 2 diabetes.
Ventricular Arterial Coupling Surrogates Predict Mortality and Adverse Events in Acute Heart Failure
Ventricular-arterial coupling measures help identify high risk in heart failure
Meta-analysis of 36,989 patients reveals that RV-PA uncoupling predicts mortality while LV-Ao uncoupling identifies risk for in-hospital car…
New data shows that specific heart measurements can help doctors identify which heart failure patients face the highest risk of death or com…
Longer heart failure duration correlates with lower LV strain and higher HF event risk
Longer Heart Failure Duration Tied to Worse Heart Structure and Function
This randomized controlled trial of 626 patients with heart failure with preserved ejection fraction (HFpEF) found that longer diagnosis dur…
In a 626-patient study, people who had heart failure longer showed weaker heart pumping and higher risk of worsening symptoms.
Conduction-system pacing shows no significant improvement over biventricular pacing in heart failure patients
New pacing methods show no major gains over standard treatment
This meta-analysis of 976 patients with HFrEF undergoing CRT found that conduction-system pacing (CSP) did not significantly improve LVEF, h…
A review of 976 patients shows that a newer heart pacing method does not outperform the current standard for heart failure survival.